Table 2.

Findings of follow-up at 1 week

Adverse events	Cu 375 (n = 50)	CuT380A (n = 50)	p value
Heavy bleeding	5 (10%)	6 (12%)	0.75
Pelvic pain	7 (14%)	6 (12%)	0.77
Pelvic infection	0	0
Expulsion	1 (2%)	2 (4%)	0.56